Literature DB >> 20530236

Genetic variation at chromosome 8q24 in osteosarcoma cases and controls.

Lisa Mirabello1, Sonja I Berndt, Guillermo F Seratti, Laurie Burdett, Meredith Yeager, Salma Chowdhury, Kedest Teshome, Arinze Uzoka, Chester Douglass, Richard B Hayes, Robert N Hoover, Sharon A Savage.   

Abstract

Osteosarcoma is a primary bone malignancy that typically occurs during the pubertal growth spurt. Only a few small association studies have evaluated common germ line variation in individuals with osteosarcoma. The 8q24 chromosomal region contains several loci that are associated with risk of many different cancers. We conducted an association study of common single-nucleotide polymorphisms (SNPs) across 8q24 to explore the role this region may play in osteosarcoma risk. We genotyped 214 tag SNPs in 99 osteosarcoma cases and 1430 controls (65 controls from a hospital-based case-control study and 1365 controls from a population-based study). Additive, dominant and recessive genetic models were evaluated using unconditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Analyses of nine SNPs previously associated with cancer did not show strong statistically significant associations. Of the remaining 205 SNPs, 7 were statistically significant (P </= 0.05) in one or more genetic models; the most significant association was observed for the additive effect of the minor allele at rs896324 (OR 1.75, 95% CI 1.13-2.69, P = 0.01). This study suggests that several SNPs in 8q24 may be associated with osteosarcoma, but the susceptibility observed was modest. Future large studies of osteosarcoma genetic risk factors are warranted to improve our understanding of the genetic contribution to this cancer of adolescents and young adults.

Entities:  

Mesh:

Year:  2010        PMID: 20530236      PMCID: PMC2915635          DOI: 10.1093/carcin/bgq117

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  51 in total

1.  The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.

Authors:  Sari Tuupanen; Mikko Turunen; Rainer Lehtonen; Outi Hallikas; Sakari Vanharanta; Teemu Kivioja; Mikael Björklund; Gonghong Wei; Jian Yan; Iina Niittymäki; Jukka-Pekka Mecklin; Heikki Järvinen; Ari Ristimäki; Mariachiara Di-Bernardo; Phil East; Luis Carvajal-Carmona; Richard S Houlston; Ian Tomlinson; Kimmo Palin; Esko Ukkonen; Auli Karhu; Jussi Taipale; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

2.  A case-control study of osteosarcoma in young persons.

Authors:  E A Operskalski; S Preston-Martin; B E Henderson; B R Visscher
Journal:  Am J Epidemiol       Date:  1987-07       Impact factor: 4.897

3.  Stature and malignant tumors of bone in childhood and adolescence.

Authors:  J F Fraumeni
Journal:  Cancer       Date:  1967-06       Impact factor: 6.860

4.  Chromosomal regions involved in the pathogenesis of osteosarcomas.

Authors:  C Stock; L Kager; F M Fink; H Gadner; P F Ambros
Journal:  Genes Chromosomes Cancer       Date:  2000-07       Impact factor: 5.006

5.  Sustained loss of a neoplastic phenotype by brief inactivation of MYC.

Authors:  Meenakshi Jain; Constadina Arvanitis; Kenneth Chu; William Dewey; Edith Leonhardt; Maxine Trinh; Christopher D Sundberg; J Michael Bishop; Dean W Felsher
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

6.  Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.

Authors:  Leo Kager; Andreas Zoubek; Ulrike Pötschger; Ulrike Kastner; Silke Flege; Beate Kempf-Bielack; Detlev Branscheid; Rainer Kotz; Mechthild Salzer-Kuntschik; Winfried Winkelmann; Gernot Jundt; Hartmut Kabisch; Peter Reichardt; Heribert Jürgens; Helmut Gadner; Stefan S Bielack
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

7.  Sporadic amplification of the MYC gene in human osteosarcomas.

Authors:  M Ladanyi; C K Park; R Lewis; S C Jhanwar; J H Healey; A G Huvos
Journal:  Diagn Mol Pathol       Date:  1993-09

8.  C-myc and c-fos in human osteosarcoma: prognostic value of mRNA and protein expression.

Authors:  G Gamberi; M S Benassi; T Bohling; P Ragazzini; L Molendini; M R Sollazzo; F Pompetti; M Merli; G Magagnoli; A Balladelli; P Picci
Journal:  Oncology       Date:  1998 Nov-Dec       Impact factor: 2.935

9.  Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Ialpha1 genes and their relationship with height in children with bone cancer.

Authors:  Elena Ruza; Elena Sotillo; Luis Sierrasesúmaga; Cristina Azcona; Ana Patiño-García
Journal:  J Pediatr Hematol Oncol       Date:  2003-10       Impact factor: 1.289

10.  Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.

Authors:  Tsz-Kwong Man; Xin-Yan Lu; Kim Jaeweon; Laszlo Perlaky; Charles P Harris; Shishir Shah; Marc Ladanyi; Richard Gorlick; Ching C Lau; Pulivarthi H Rao
Journal:  BMC Cancer       Date:  2004-08-07       Impact factor: 4.430

View more
  12 in total

Review 1.  Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.

Authors:  D Matthew Gianferante; Lisa Mirabello; Sharon A Savage
Journal:  Nat Rev Endocrinol       Date:  2017-03-24       Impact factor: 43.330

2.  Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.

Authors:  Zhen Wang; Peng Wen; Xiaojun Luo; Xiaomin Fang; Qingfeng Wang; Feng Ma; Jinhan Lv
Journal:  Tumour Biol       Date:  2013-12-06

3.  Invited commentary: more surprises from a gene desert.

Authors:  Sholom Wacholder; Meredith Yeager; Linda M Liao
Journal:  Am J Epidemiol       Date:  2012-02-20       Impact factor: 4.897

4.  Frailty modeling of age-incidence curves of osteosarcoma and Ewing sarcoma among individuals younger than 40 years.

Authors:  Morten Valberg; Tom Grotmol; Steinar Tretli; Marit B Veierød; Susan S Devesa; Odd O Aalen
Journal:  Stat Med       Date:  2012-06-29       Impact factor: 2.373

Review 5.  Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

Authors:  James J Morrow; Chand Khanna
Journal:  Crit Rev Oncog       Date:  2015

6.  Using epidemiology and genomics to understand osteosarcoma etiology.

Authors:  Sharon A Savage; Lisa Mirabello
Journal:  Sarcoma       Date:  2011-03-08

7.  GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population.

Authors:  Chaoyin Jiang; Hua Chen; Lei Shao; Yang Dong
Journal:  Med Oncol       Date:  2014-07       Impact factor: 3.064

Review 8.  Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.

Authors:  Francesco R Evola; Luciano Costarella; Vito Pavone; Giuseppe Caff; Luca Cannavò; Andrea Sessa; Sergio Avondo; Giuseppe Sessa
Journal:  Front Pharmacol       Date:  2017-04-07       Impact factor: 5.810

9.  Polymorphisms on 8q24 are associated with lung cancer risk and survival in Han Chinese.

Authors:  Xuelin Zhang; Qun Chen; Chunya He; Weihua Mao; Ling Zhang; Xiaowen Xu; Junfei Zhu; Baofu Chen
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

10.  Genome-wide association study identifies two susceptibility loci for osteosarcoma.

Authors:  Sharon A Savage; Lisa Mirabello; Zhaoming Wang; Julie M Gastier-Foster; Richard Gorlick; Chand Khanna; Adrienne M Flanagan; Roberto Tirabosco; Irene L Andrulis; Jay S Wunder; Nalan Gokgoz; Ana Patiño-Garcia; Luis Sierrasesúmaga; Fernando Lecanda; Nilgün Kurucu; Inci Ergurhan Ilhan; Neriman Sari; Massimo Serra; Claudia Hattinger; Piero Picci; Logan G Spector; Donald A Barkauskas; Neyssa Marina; Silvia Regina Caminada de Toledo; Antonio S Petrilli; Maria Fernanda Amary; Dina Halai; David M Thomas; Chester Douglass; Paul S Meltzer; Kevin Jacobs; Charles C Chung; Sonja I Berndt; Mark P Purdue; Neil E Caporaso; Margaret Tucker; Nathaniel Rothman; Maria Teresa Landi; Debra T Silverman; Peter Kraft; David J Hunter; Nuria Malats; Manolis Kogevinas; Sholom Wacholder; Rebecca Troisi; Lee Helman; Joseph F Fraumeni; Meredith Yeager; Robert N Hoover; Stephen J Chanock
Journal:  Nat Genet       Date:  2013-06-02       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.